The factor XIa inhibitor reduced the rate of disabling/fatal strokes versus placebo, with a consistent net clinical benefit.

HELSINKI, Finland—Patients with atrial fibrillation (AF) who have had an ischemic stroke continue to have a high risk of recurrent stroke even when they’re treated with oral anticoagulation, a ...

Nearly 1 in 4 people who have previously had a stroke will experience a recurrent stroke. To help reduce this risk, clinicians will typically recommend antiplatelet or anticoagulant therapy, in ...

Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the ...

This article describes the clinical and economic impact of ischemic stroke, including the particular burden of recurrent stroke. Thereafter, it reviews the treatment landscape for recurrent stroke, ...

Surviving a stroke represents a significant health victory, but many survivors don’t realize they’ve entered a high-risk category for experiencing another event. Understanding why stroke lightning can ...

In a large, long-term trial, cilostazol was as effective as aspirin at preventing recurrent stroke and was associated with fewer hemorrhages. Antiplatelet drugs have an established role in secondary ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Patients who have had a stroke are prescribed medication to prevent new strokes. Nevertheless, fewer than half achieve the optimal treatment targets. A sample of 431 Norwegian patients who had ...

In Danish women with a history of ischemic stroke, use of vaginal estradiol tablets was not associated with an increased rate of recurrent ischemic stroke. Results suggest these women may not be so ...

AJMC®: How commonly do you see patients or treat patients for recurrent stroke in the hospital setting? AMIN: In the hospital setting, approximately 15% to 30% of patients experience a recurrent ...